Shire proposed combination with Baxalta
Strong strategic fit and industry-leading portfolio of combined company is projected to deliver immediate value creation and generate $20 billion in product sales by 2020
Download the full Press Release
Copyright 1995-2020 Takeda Pharmaceutical Company Limited. All rights reserved.